Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 20;17(12):e0278825.
doi: 10.1371/journal.pone.0278825. eCollection 2022.

Characteristics and predictors of Long COVID among diagnosed cases of COVID-19

Affiliations

Characteristics and predictors of Long COVID among diagnosed cases of COVID-19

M C Arjun et al. PLoS One. .

Abstract

Background: Long COVID or long-term symptoms after COVID-19 has the ability to affect health and quality of life. Knowledge about the burden and predictors could aid in their prevention and management. Most of the studies are from high-income countries and focus on severe acute COVID-19 cases. We did this study to estimate the incidence and identify the characteristics and predictors of Long COVID among our patients.

Methodology: We recruited adult (≥18 years) patients who were diagnosed as Reverse Transcription Polymerase Chain Reaction (RTPCR) confirmed SARS-COV-2 infection and were either hospitalized or tested on outpatient basis. Eligible participants were followed up telephonically after four weeks and six months of diagnosis of SARS-COV-2 infection to collect data on sociodemographic, clinical history, vaccination history, Cycle threshold (Ct) values during diagnosis and other variables. Characteristics of Long COVID were elicited, and multivariable logistic regression was done to find the predictors of Long COVID.

Results: We have analyzed 487 and 371 individual data with a median follow-up of 44 days (Inter quartile range (IQR): 39,47) and 223 days (IQR:195,251), respectively. Overall, Long COVID was reported by 29.2% (95% Confidence interval (CI): 25.3%,33.4%) and 9.4% (95% CI: 6.7%,12.9%) of participants at four weeks and six months of follow-up, respectively. Incidence of Long COVID among patients with mild/moderate disease (n = 415) was 23.4% (95% CI: 19.5%,27.7%) as compared to 62.5% (95% CI: 50.7%,73%) in severe/critical cases(n = 72) at four weeks of follow-up. At six months, the incidence among mild/moderate (n = 319) was 7.2% (95% CI:4.6%,10.6%) as compared to 23.1% (95% CI:12.5%,36.8%) in severe/critical (n = 52). The most common Long COVID symptom was fatigue. Statistically significant predictors of Long COVID at four weeks of follow-up were-Pre-existing medical conditions (Adjusted Odds ratio (aOR) = 2.00, 95% CI: 1.16,3.44), having a higher number of symptoms during acute phase of COVID-19 disease (aOR = 11.24, 95% CI: 4.00,31.51), two doses of COVID-19 vaccination (aOR = 2.32, 95% CI: 1.17,4.58), the severity of illness (aOR = 5.71, 95% CI: 3.00,10.89) and being admitted to hospital (Odds ratio (OR) = 3.89, 95% CI: 2.49,6.08).

Conclusion: A considerable proportion of COVID-19 cases reported Long COVID symptoms. More research is needed in Long COVID to objectively assess the symptoms and find the biological and radiological markers.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow chart showing the selection of study participants and follow-up at four weeks and six months.
Fig 2
Fig 2. Percentage of self-reported Long COVID symptoms at four weeks and six months of follow-up.

Similar articles

  • Long COVID following Omicron wave in Eastern India-A retrospective cohort study.
    Arjun MC, Singh AK, Roy P, Ravichandran M, Mandal S, Pal D, Das K, Gajjala A, Venkateshan M, Mishra B, Patro BK, Mohapatra PR, Subba SH. Arjun MC, et al. J Med Virol. 2023 Jan;95(1):e28214. doi: 10.1002/jmv.28214. Epub 2022 Oct 25. J Med Virol. 2023. PMID: 36224705 Free PMC article.
  • Female gender is associated with long COVID syndrome: a prospective cohort study.
    Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mulè G, Augello M, Mondatore D, Allegrini M, Cona A, Tesoro D, Tagliaferri G, Viganò O, Suardi E, Tincati C, Beringheli T, Varisco B, Battistini CL, Piscopo K, Vegni E, Tavelli A, Terzoni S, Marchetti G, Monforte AD. Bai F, et al. Clin Microbiol Infect. 2022 Apr;28(4):611.e9-611.e16. doi: 10.1016/j.cmi.2021.11.002. Epub 2021 Nov 9. Clin Microbiol Infect. 2022. PMID: 34763058 Free PMC article.
  • Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection.
    Funk AL, Kuppermann N, Florin TA, Tancredi DJ, Xie J, Kim K, Finkelstein Y, Neuman MI, Salvadori MI, Yock-Corrales A, Breslin KA, Ambroggio L, Chaudhari PP, Bergmann KR, Gardiner MA, Nebhrajani JR, Campos C, Ahmad FA, Sartori LF, Navanandan N, Kannikeswaran N, Caperell K, Morris CR, Mintegi S, Gangoiti I, Sabhaney VJ, Plint AC, Klassen TP, Avva UR, Shah NP, Dixon AC, Lunoe MM, Becker SM, Rogers AJ, Pavlicich V, Dalziel SR, Payne DC, Malley R, Borland ML, Morrison AK, Bhatt M, Rino PB, Beneyto Ferre I, Eckerle M, Kam AJ, Chong SL, Palumbo L, Kwok MY, Cherry JC, Poonai N, Waseem M, Simon NJ, Freedman SB; Pediatric Emergency Research Network–COVID-19 Study Team. Funk AL, et al. JAMA Netw Open. 2022 Jul 1;5(7):e2223253. doi: 10.1001/jamanetworkopen.2022.23253. JAMA Netw Open. 2022. PMID: 35867061 Free PMC article.
  • Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, Obeidat M, Obeidat Y, Gerberi D, Taha RM, Kashour Z, Kashour T, Berbari EF, Alkattan K, Tleyjeh IM. Alkodaymi MS, et al. Clin Microbiol Infect. 2022 May;28(5):657-666. doi: 10.1016/j.cmi.2022.01.014. Epub 2022 Feb 3. Clin Microbiol Infect. 2022. PMID: 35124265 Free PMC article. Review.
  • One-Year Temporal Changes in Long COVID Prevalence and Characteristics: A Systematic Review and Meta-Analysis.
    Huang Q, Jia M, Sun Y, Jiang B, Cui D, Feng L, Yang W. Huang Q, et al. Value Health. 2023 Jun;26(6):934-942. doi: 10.1016/j.jval.2022.11.011. Epub 2022 Nov 25. Value Health. 2023. PMID: 36436792 Review.

Cited by

References

    1. WHO Director-General’s opening remarks at the media briefing on COVID-19–30 March 2020 [Internet]. 2020 [cited 2021 Dec 13]. Available from: https://www.who.int/director-general/speeches/detail/who-director-genera....
    1. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard with Vaccination Data [Internet]. 2021. [cited 2021 Dec 13]. Available from: https://covid19.who.int/.
    1. World health organization. The latest on the covid-19 global situation & long-term sequelae [Internet]. 2021. [cited 2021 Dec 13]. Available from: https://www.who.int/publications/m/item/update-54-clinical-long-term-eff....
    1. Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426 - DOI - PMC - PubMed
    1. Baig AM. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021;93(5):2555–6. doi: 10.1002/jmv.26624 - DOI - PubMed

Substances

Grants and funding

The authors received no specific funding for this work.
-